Discover the top sales and marketing intelligence solutions tailored for the pharmaceutical industry. Download our guide to predictive analytics and data-driven insights.

While A.I. promises breakthroughs, industry leaders warn that transparency and patient safety must remain front and center.

In the global pharmaceutical industry, there were three private equity deals announced in Q3 2024, worth a total value of $4.2m, according to GlobalData's Deals Database.

The integration of AI into drug submission and approval processes signifies a shift towards more efficient pharmaceutical development. The potential benefits are substantial, including faster ...

Healx will use its AI-based drug discovery tech to analyze proprietary Sanofi compound data and identify potential rare disease targets.

Citeline and Norstella have completed a merger, first announced in June, to create one of the largest players in the pharmaceutical intelligence category. Citeline provides intelligence ...

Robert F. Kennedy Jr. has been angling for a role in the Trump administration since he endorsed the president-elect in August ...

We often delay to credit real intelligence behind Artificial intelligence platforms and tools. The professionals—engineers, ...

Partnered with multiple neuroscience pharmaceutical companies, including Bright Minds Bioscience, and neurologists to advance Company’s dual go-to-market strategy ...

Integrating novel technologies in drug development and quality control, such as big data analytics, artificial intelligence, ...

Amid tightening EU regulations, a growing emphasis on digitalisation and artificial intelligence (AI), and complex questions ...

Tempus AI's growth and partnerships make it an attractive investment. See why TEM stock is a solid Buy due to its ...